Indiana Hemophilia & Thrombosis Center Inc
The Indiana Hemophilia & Thrombosis Center Inc (IHTC) is an Indianapolis-based public charity that provides comprehensive care and services for people with bleeding, clotting, and other hematologic disorders and their families. Established in 1998, it serves pediatric and adult patients throughout Indiana and describes itself as the state’s only federally recognized comprehensive hemophilia treatment center.
Indiana Hemophilia & Thrombosis Center Inc at a glance
In short: Indiana Hemophilia & Thrombosis Center Inc gave $3.6M across 10 grants in 2024 (avg $359K), mostly in Indiana. 0% of 2024 grantees were new. Source: 2024 IRS Form 990.
- Annual giving (2024)
- $3,587,658
- +62.9% vs 2023
- Grants made (2024)
- 10
- +11.1% vs 2023
- Average grant
- $358,766
- +46.6% vs 2023
- Median grant
- $127,500
- Total assets
- $74,045,300
- -65.4% vs 2023
- New grantees (estimate)
- 0% first-time grantees (0 of 10, 2024; small sample)
- Primary geography
- Indiana (59% of itemized 2024 grant dollars)
- Latest 990 filing
- Form 990, 2024 View filing
Data from IRS Form 990, 2024; updated October 2026. New grantees are estimated by matching recipient names across years (methodology).
How to apply to Indiana Hemophilia & Thrombosis Center Inc
- Contact
Mailing address: 8326 Naab Rd, Indianapolis, IN 46260-1920
Phone: (317) 871-0000
Website: https://ihtc.org
Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.
Who Indiana Hemophilia & Thrombosis Center Inc funds
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
The largest 2024 recipient was Community Health Clinic ($1.5M). Together the top 10 received $3.6M.
Grant Size Distribution
47 grants across all recorded years
The most common grant size was in the $50–100K range: 15 grants of 47 (32%).
Geographic Focus
Where this funder awards grants
IHTC’s filing says it serves pediatric and adult patients throughout Indiana, and its website describes statewide outreach clinics, local nursing support, and home visits. In 2024, 59% of its grant dollars went to recipients in Indiana, 22% to Michigan, 10% to Illinois, 5% to New York, and 4% to Virginia.
Grant Distribution by State
Share of 2024 grant dollars across all 10 itemized grants.
Cities
Is Indiana Hemophilia & Thrombosis Center Inc open to new grantees?
0%
first-time grantees, 2024
In 2024, 0 of 10 grantees (0%) were first-time recipients. With only 10 grantees, that is a small sample: one grantee more or less moves the share by about 10 points. How we count
Estimate from itemized grant lists in IRS Form 990 filings (2020–2024). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2024, annual grant giving ranged from $489K (2020) to $4.6M (2021). In 2024 it made 10 grants totaling $3.6M.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| Community Health Clinic Topeka, IN | See Part IV | $1,501,367 |
| Hemophilia Foundation of Michigan Ypsilanti, MI | See Part IV | $693,392 |
| Hemophilia of Indiana Indianapolis, IN | See Part IV | $598,016 |
| American Thrombosis & Hemostasis Network Riverwoods, IL | See Part IV | $350,438 |
| Accessia Health Midlothian, VA | See Part IV | $155,000 |
| World Federation of Hemophilia USA Albany, NY | See Part IV | $100,000 |
| Indiana University - Dept 78867 Detroit, MI | See Part IV | $86,606 |
| National Bleeding Disorders Foundation New York, NY | See Part IV | $75,000 |
| The Martin Center Indianapolis, IN | See Part IV | $17,839 |
| Children's Museum of Indianapolis Indianapolis, IN | See Part IV | $10,000 |
Ready to take the next step with Indiana Hemophilia & Thrombosis Center Inc?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2024 | $74,045,300 | $39,420,575 | $45,183,867 | $3,587,658 | 10 | $520,020 |
| 2023 | $214,000,867 | $56,975,342 | $56,574,065 | $2,202,043 | 9 | $6,323,426 |
| 2022 | $205,388,132 | $55,708,442 | $48,585,161 | $680,450 | 9 | $5,823,824 |
| 2021 | $231,660,883 | $58,709,453 | $45,391,063 | $4,622,251 | 12 | $10,219,497 |
| 2020 | $214,767,252 | $47,732,836 | $37,172,453 | $489,320 | 7 | $3,154,323 |
Research compiled by Grantable AI from public sources. Last updated October 2026.
Mission & Focus Areas
IHTC states that it is committed to providing high-quality comprehensive services and holistic care to patients with bleeding, clotting, and other hematologic disorders and their families. Its filing describes patient care, clinical research, and education for medical students, residents, fellows, patients, families, and community members.
IHTC’s 2024 grants supported a range of organizations and activities. The filing identifies a contract with The Martin Center for transportation and assistance initiatives, a patient education conference, and social services; support for a hematology fellowship program at Indiana University; and patient assistance, services, and program support through Hemophilia of Indiana. It also describes support for bleeding disorders awareness and a community health exhibit at the Children’s Museum of Indianapolis, medical and dental care for underserved and vulnerable populations through Community Health Clinic, and the World Federation of Hemophilia USA’s Living Guidelines Project.
The grantees’ stated missions illustrate the range of organizations supported. Hemophilia Foundation of Michigan says it works to improve quality of life for people affected by hemophilia and related disorders. Hemophilia of Indiana says it supports the treatment and cure of hemophilia and related bleeding disorders through research, education, and service. Accessia Health describes its mission as providing financial assistance and services to people and families living with chronic medical conditions. The National Bleeding Disorders Foundation says it works on research, education, advocacy, and preventing complications of inherited blood and bleeding disorders. The Martin Center says it provides services, advocacy, and education for people affected by sickle cell and associated disorders. These are the grantees’ missions, not IHTC’s.
Grantmaking
In filing year 2024, IHTC reported 10 grants totaling $3,587,658. Grant amounts ranged from $10,000 to $1,501,367, with a median of $127,500.
Among the largest grants were $1,501,367 to Community Health Clinic, $693,392 to Hemophilia Foundation of Michigan, $598,016 to Hemophilia of Indiana, and $350,438 to the American Thrombosis & Hemostasis Network. Other reported grants included $155,000 to Accessia Health, $100,000 to World Federation of Hemophilia USA, $86,606 to Indiana University, $75,000 to the National Bleeding Disorders Foundation, $17,839 to The Martin Center, and $10,000 to the Children’s Museum of Indianapolis.
The filing describes several awards as contracts for services or program support.
Leadership & Key People
Leadership team and compensation from IRS filings
The 2024 filing lists Amy D. Shapiro, MD, as president/CEO and medical director; Anne Greist, MD, as director and medical director; Russell Sherlock as chairman; Chris Roberson as chief research officer and secretary; and Eric Gray as chief operations officer. Other listed directors are Dennis Casey, Edward Schmidt, James Gilroy III, Phillip Himelstein, and Jennifer Maahs, director of clinical care.
Indiana Hemophilia & Thrombosis Center Inc is led by Amy D. Shapiro MD, President, CEO & Medical Director on every filing since 2020; all 20 officers listed in 2024 are compensated.
Officers on the 2024 filing
Amy D. Shapiro MD
President, CEO & Medical Director
On filings since 2020
10 hrs/week
$869K (2020) → $211K (2024)
Nancy Hoard
Executive Director
On filings since 2020
17 hrs/week
$477K (2020) → $184K (2024)
Russell Sherlock
Chairman
Director → Chairman, 2024
On filings since 2020
3 hrs/week
$71K (2020) → $14K (2024)
Anne Greist MD
Director & Medical Director
On filings since 2020
5 hrs/week
$653K (2020) → $92K (2024)
Dennis Casey
Director
On filings since 2020
2 hrs/week
$61K (2020) → $9K (2024)
Edward Schmidt
Director
Secretary & Consultant → Director, 2024
On filings since 2020
2 hrs/week
$160K (2020) → $9K (2024)
Kelly McCarthy
Director of Multidisciplinary T
Director of Clinical Opera → Director of Multidisciplinary Teams & Quality Analytics, 2021
Director of Multidisciplinary Teams & Quality Analytics → Director of Multidisciplinary T, 2022
On filings since 2020
31 hrs/week
$235K (2020) → $209K (2024)
Phillip Himelstein
Director
Chairman & Consultant → Director, 2024
On filings since 2020
2 hrs/week
$137K (2020) → $9K (2024)
Jennifer Maahs
Director of Clinical Care
Director of Clinical Care Operations → Director of Clinical Care, 2022
On filings since 2021
29 hrs/week
$191K (2021) → $189K (2024)
Stevan Mizimakoski
Director of Pharmacy Opera
Director of Pharmacy Operations → Director of Pharmacy Opera, 2022
On filings since 2021
23 hrs/week
$167K (2021) → $116K (2024)
James Gilroy III
Director
New on the 2024 filing
3 hrs/week
$33K (2024)
Brandon Hardesty MD
Hematologist
On filings since 2020
13 hrs/week
$441K (2020) → $169K (2024)
Chris Roberson
Chief Research Officer & Secretary
Director of Medical Program → Chief Research Officer, 2023
Chief Research Officer → Chief Research Officer & Secretary, 2024
On filings since 2020
26 hrs/week
$262K (2020) → $208K (2024)
David Hedrick MD
Hematologist
On filings since 2020
13 hrs/week
$434K (2020) → $168K (2024)
Eric Gray
Chief Operations Officer
Director of Finance, Bus Ops & C → Chief Operations Officer, 2023
On filings since 2020
18 hrs/week
$363K (2020) → $181K (2024)
Jay Gaddy MD
Hematologist
On filings since 2020
14 hrs/week
$497K (2020) → $175K (2024)
Magdalena Lewandowska MD
Hematologist
On filings since 2020
13 hrs/week
$433K (2020) → $165K (2024)
Anthony Betbadal MD
Hematologist
On filings since 2021
15 hrs/week
$388K (2021) → $172K (2024)
Kevin Simmons
Chief Financial Officer
New on the 2024 filing
37 hrs/week
$190K (2024)
Sanjya Ahuja MD
Chief Medical & Informatics Officer
New on the 2024 filing
12 hrs/week
$34K (2024)
Former officers (10)
- Former: Jennifer Rhodes (2020–2023) — Director
- Former: Leah Meyer Austin (2020–2023) — Director
- Former: Patricia Roe (2020–2023) — Director
- Former: Holiday Hart McKiernan (2021–2023) — Director
- Former: Jeffery Martin (2021–2023) — Director
- Former: Sherry Slick (2022–2023) — Chief Information Officer
- Former: Michael Oestreicher (2020–2022) — Director
- Former: Anthony Antonopoulos (2020) — Former Key Employee
- Former: Kevin Betz (2020) — Former Director
- Former: Nicole Randall MD (2020) — Hematologist
Data from IRS Form 990 filings, 2020–2024. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2024 IRS filing
The highest reported compensation on the 2024 filing was $211K, to Amy D Shapiro MD (President/CEO, Medical DIR). 20 officers or directors reported compensation on that filing.
Frequently asked questions about Indiana Hemophilia & Thrombosis Center Inc
How much does Indiana Hemophilia & Thrombosis Center Inc give each year?
Indiana Hemophilia & Thrombosis Center Inc gave $3.6M across 10 grants in 2024, according to its 2024 IRS Form 990. In 2023 it gave $2.2M across 9 grants.
What is Indiana Hemophilia & Thrombosis Center Inc's typical grant size?
Indiana Hemophilia & Thrombosis Center Inc's median grant in 2024 was $127,500, and its average grant was $358,766, across 10 grants on its 2024 IRS Form 990.
Where does Indiana Hemophilia & Thrombosis Center Inc give grants?
Indiana Hemophilia & Thrombosis Center Inc gives mostly in Indiana: 59% of the grant dollars itemized on its 2024 IRS Form 990 went to recipients there. The next largest states were Michigan (22%) and Illinois (10%). The most frequent recipient cities were Indianapolis, IN (3 grants).
Does Indiana Hemophilia & Thrombosis Center Inc give general operating support?
Not in 2024: none of the 10 grants with a stated purpose on Indiana Hemophilia & Thrombosis Center Inc's 2024 IRS Form 990 were described as general or operating support. Recurring purposes include "See Part IV" (10 grants).
Who are Indiana Hemophilia & Thrombosis Center Inc's largest grantees?
Indiana Hemophilia & Thrombosis Center Inc's largest 2024 grantees include Community Health Clinic ($1,501,367), Hemophilia Foundation of Michigan ($693,392) and Hemophilia of Indiana ($598,016), according to its 2024 IRS Form 990. Together they received 78% of its itemized 2024 grant dollars.
How large is Indiana Hemophilia & Thrombosis Center Inc?
Indiana Hemophilia & Thrombosis Center Inc reported $74.0M in total assets on its 2024 IRS Form 990. Its revenue that year was $39.4M.
What does Indiana Hemophilia & Thrombosis Center Inc fund?
IHTC states that it is committed to providing high-quality comprehensive services and holistic care to patients with bleeding, clotting, and other hematologic disorders and their families. See mission & focus areas ↑
How do I apply for a grant from Indiana Hemophilia & Thrombosis Center Inc?
Indiana Hemophilia & Thrombosis Center Inc has no public application process in the sources Grantable reviewed. Check ihtc.org for current guidelines, or contact the foundation directly before submitting a request.
What is Indiana Hemophilia & Thrombosis Center Inc's EIN?
Indiana Hemophilia & Thrombosis Center Inc's EIN (Employer Identification Number) is 35-2047838. IRS Form 990 filing data is available on this page for 2020–2024.
Data last updated October 2026. Sourced from IRS Form 990 filings. Research dossier generated October 2026.
Data update history
(6)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS November 12, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS November 14, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS November 14, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS November 15, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS November 15, 2025)
- IRS filings on file for fiscal years 2020–2024
Live grants for the work Indiana Hemophilia & Thrombosis Center Inc funds
Health Open opportunities, soonest deadline first.
Explore Open Grants
Browse active grant opportunities in Indiana Hemophilia & Thrombosis Center Inc's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
The Hemophilia Alliance Group Purchasing Organization
Clearwater, FL
The Hemophilia Alliance Group Purchasing funds organizations supporting people with bleeding and clotting disorders, including advocacy, education, research, and care at treatment centers. In 2024, it made seven grants ranging from $8,012 to $869,000, with a median of $402,000, to recipients in New York, Pennsylvania, Indiana, and Wisconsin. The profile does not state whether it accepts unsolicited requests.
Assets
$26.0M
Grants
7
Total Given
$3.0M
National Bleeding Disorders Foundation
New York, NY
NBDF funds research on inheritable bleeding and blood disorders, as well as education, advocacy, and support for affected communities and organizations. Its 2024 grants ranged from $5,250 to $200,000, with a median of $14,000, and went to recipients across the United States and Puerto Rico; research applicants must be affiliated with a U.S.-based organization. The profile describes applications for specific research awards but does not state whether NBDF accepts unsolicited requests.
Assets
$30.8M
Grants
23
Total Given
$839K
Enterprise Holdings Foundation
Saint Louis, MO
The Enterprise Holdings Foundation supports charitable and educational nonprofits in communities where Enterprise Mobility operates, focusing on health, education, arts, and disaster relief; applicants must be actively supported by an Enterprise Mobility team member, spouse, or domestic partner. Giving varies widely: it reported 9,499 grants in 2024, but its 2025 filing showed one grant of $101.4 million, so that amount is not a typical award. Applications are accepted at any time through eligible Enterprise-affiliated applicants; the Foundation does not limit giving to preselected organizations.
Assets
$594.3M
Grants
1
Total Given
$101.4M
University of Kansas Medical Center Research Institute
Kansas City, KS
The University of Kansas Medical Center Research Institute administers funding for medical, scientific, educational, and service projects led by KUMC faculty, with a focus on research partnerships and biomedical discovery. Its 2025 filing reports one grant of $19.2 million, all of that year’s grant funding going to a Kansas recipient. The profile does not state whether it accepts unsolicited requests.
Assets
$228.5M
Grants
1
Total Given
$19.2M
Positudes Inc DBA the Alliance Pharmacy
Westbury, NY
Assets
$39.5M
Grants
9
Total Given
$496K
The Hemophilia Alliance Foundation
Clearwater, FL
The Hemophilia Alliance Foundation funds eligible organizations and programs serving people with inherited bleeding and thrombotic disorders, including organizational capacity, patient assistance, regional treatment centers, and education. Recent grants ranged from $6,287 to $34,000, with a median of $8,000; its awards support organizations across the United States. Grant applications are available annually, but the profile does not state whether unsolicited requests are accepted.
Assets
$71K
Grants
73
Total Given
$805K
More similar funders
More Funders in Indiana
Cite this profile
Grantable. (2026). Indiana Hemophilia & Thrombosis Center Inc funder profile. GrantGraph. Retrieved October 23, 2026, from https://grantable.co/funders/indiana-hemophilia-and-thrombosis-center-inc-morg_816c998122c44aedad68077faa13a1e5
BibTeX
@misc{grantable_352047838_2026,
author = {{Grantable}},
title = {{Indiana Hemophilia \& Thrombosis Center Inc funder profile}},
howpublished = {GrantGraph},
year = {2026},
url = {https://grantable.co/funders/indiana-hemophilia-and-thrombosis-center-inc-morg_816c998122c44aedad68077faa13a1e5},
note = {Accessed 2026-10-23. Data licensed CC BY 4.0}
}The figures on this page are open data under CC BY 4.0: reuse them with credit to Grantable and a link. Download the data.
Figures come from Indiana Hemophilia & Thrombosis Center Inc's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
Indiana Hemophilia & Thrombosis Center Inc down — hundreds of funders to go?